Virginia 2023 Regular Session

Virginia House Bill HB1809

Introduced
1/10/23  

Caption

Newborn screening; Krabbe disease and other lysosomal storage disorders.

Impact

If enacted, HB1809 would amend the specific code outlining newborn screening requirements, thereby updating and expanding the types of disorders for which infants must be tested. The inclusion of Krabbe disease signifies a proactive approach to congenital disorders, potentially reducing the long-term healthcare costs associated with late diagnoses. Additionally, the bill ensures that screening procedures must be conducted reliably and could improve overall public health outcomes by ensuring timely intervention when disorders are detected.

Summary

House Bill 1809 focuses on enhancing the health screenings of newborns in the Commonwealth of Virginia. The bill mandates that every infant born within the state undergo screening tests for several disorders, specifically including Krabbe disease and other lysosomal storage disorders. This measure is aimed at preventing intellectual disabilities, permanent disabilities, or even death in infants by ensuring early detection and management of these conditions. The legislation aligns with recommendations from health authorities regarding uniform screening panels for newborns, helping to streamline health protocols across hospitals and healthcare facilities.

Contention

While the bill primarily garners support from healthcare advocates and professionals emphasizing the importance of early disease detection, there are notable concerns regarding parental rights. The legislation includes provisions that allow parents or guardians to object to the screenings on religious grounds, which has prompted discussions about the balance between public health and individual rights. Ensuring parents are informed about the necessity and benefits of such tests while respecting their beliefs remains a point of contention among stakeholders.

Voting_history

The bill's voting history indicates that it was reviewed by a subcommittee, which unanimously recommended striking it from the docket, reflecting potential challenges in garnering widespread legislative support. The discussions surrounding the bill highlight a growing tension between advancing public health initiatives and accommodating diverse perspectives within the community.

Companion Bills

No companion bills found.

Previously Filed As

VA HB740

Relating to newborn screening for critical congenital heart disease and other disorders.

VA HB1782

Newborn screening requirements; federal Recommended Uniform Screening Panel, evaluation, report.

VA HB2224

Newborn screening program; VDH & DGS, et al., to evaluate current funding model.

VA SB00285

An Act Concerning Newborn Screening For Krabbe Disease.

VA SB625

Newborn screening: genetic diseases: blood samples collected.

VA HB283

Requires screening of newborns for Krabbe disease (EN +$798,907 GF EX See Note)

VA SB1092

Relating to the screening of newborns for sickle-cell trait and other disorders by the Department of State Health Services.

VA SCR17

Directs the Department of Health and Hospitals to evaluate and report on the health benefits and costs of adding Krabbe disease to the list of mandatory screenings performed on newborns under certain circumstances.

VA SB105

AN ACT relating to newborn and infant screenings.

VA HB374

AN ACT relating to newborn and infant screenings.

Similar Bills

No similar bills found.